Roivant Sciences Ltd (NASDAQ: ROIV) is -7.52% lower on its value in year-to-date trading and has touched a low of $9.69 and a high of $13.06 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ROIV stock was last observed hovering at around $10.74 in the last trading session, with the day’s gains setting it 0.2%.
Currently trading at $10.94, the stock is -5.69% and -7.35% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.66 million and changing 1.86% at the moment leaves the stock -3.88% off its SMA200. ROIV registered -0.45% loss for a year compared to 6-month gain of -4.87%. The firm has a 50-day simple moving average (SMA 50) of $11.8242 and a 200-day simple moving average (SMA200) of $11.38125.
The stock witnessed a -9.66% loss in the last 1 month and extending the period to 3 months gives it a -8.07%, and is -4.95% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.60% over the week and 3.00% over the month.
Roivant Sciences Ltd (ROIV) has around 908 employees, a market worth around $7.96B and $125.68M in sales. Current P/E ratio is 1.93. Profit margin for the company is 3827.42%. Distance from 52-week low is 12.90% and -16.20% from its 52-week high. The company has generated returns on investments over the last 12 months (92.57%).
with sales reaching $5M over the same period.The EPS is expected to shrink by -114.65% this year, but quarterly earnings will post -4.28% year-over-year. Quarterly sales are estimated to shrink -86.54% in year-over-year returns.
Roivant Sciences Ltd (ROIV) Top Institutional Holders
393.0 institutions hold shares in Roivant Sciences Ltd (ROIV), with institutional investors hold 111.80% of the company’s shares. The shares outstanding are 733.33M, and float is at 376.90M with Short Float at 11.54%. Institutions hold 79.47% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 71.36 million shares valued at $754.29 million. The investor’s holdings represent 8.8884% of the ROIV Shares outstanding. As of 2024-06-30, the second largest holder is VIKING GLOBAL INVESTORS LP with 69.16 million shares valued at $730.98 million to account for 8.6137 of the shares outstanding. The other top investors are QVT FINANCIAL LP which holds 66.72 million shares representing 8.3103% and valued at over $705.23 million, while FMR LLC holds 5.7982 of the shares totaling 46.55 million with a market value of $492.05 million.
Roivant Sciences Ltd (ROIV) Insider Activity
The most recent transaction is an insider sale by Venker Eric, the company’s President & COO. SEC filings show that Venker Eric sold 176,900 shares of the company’s common stock on Dec 27 ’24 at a price of $11.82 per share for a total of $2.09 million. Following the sale, the insider now owns 0.67 million shares.
Roivant Sciences Ltd disclosed in a document filed with the SEC on Dec 30 ’24 that Venker Eric (President & COO) sold a total of 177,704 shares of the company’s common stock. The trade occurred on Dec 30 ’24 and was made at $11.54 per share for $2.05 million. Following the transaction, the insider now directly holds 0.74 million shares of the ROIV stock.
Still, SEC filings show that on Dec 27 ’24, Venker Eric (Officer) Proposed Sale 360,000 shares at an average price of $11.75 for $4.23 million. The insider now directly holds shares of Roivant Sciences Ltd (ROIV).
